| DNA methylation on cytosine within a CG sequence |
| negative regulation of vascular associated smooth muscle cell apoptotic process |
| negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching |
| negative regulation of cell differentiation involved in phenotypic switching |
| negative regulation of phenotypic switching |
| regulation of vascular smooth muscle cell differentiation involved in phenotypic switching |
| regulation of cell differentiation involved in phenotypic switching |
| DNA (cytosine-5-)-methyltransferase activity |
| C-5 methylation of cytosine |
| DNA-methyltransferase activity |
| DNA methylation on cytosine |
| maintenance of DNA methylation |
| negative regulation of smooth muscle cell apoptotic process |
| regulation of phenotypic switching |
| negative regulation of vascular smooth muscle cell differentiation |
| changes to DNA methylation involved in embryo development |
| DNA methylation involved in embryo development |
| regulation of vascular associated smooth muscle cell apoptotic process |
| positive regulation of methylation-dependent chromatin silencing |
| negative regulation of histone H3-K9 methylation |
| regulation of methylation-dependent chromatin silencing |
| regulation of vascular smooth muscle cell differentiation |
| positive regulation of chromatin silencing |
| pericentric heterochromatin |
| positive regulation of histone H3-K4 methylation |
| negative regulation of smooth muscle cell differentiation |
| negative regulation of histone methylation |
| regulation of histone H3-K9 methylation |
| regulation of smooth muscle cell apoptotic process |
| replication fork |
| methyl-CpG binding |
| regulation of histone H3-K4 methylation |
| regulation of smooth muscle cell differentiation |
| positive regulation of vascular smooth muscle cell proliferation |
| negative regulation of muscle cell apoptotic process |
| regulation of chromatin silencing |
| positive regulation of histone methylation |
| negative regulation of histone modification |
| DNA alkylation |
| DNA methylation |
| promoter-specific chromatin binding |
| regulation of vascular smooth muscle cell proliferation |
| negative regulation of muscle cell differentiation |
| negative regulation of chromatin organization |
| regulation of histone methylation |
| DNA methylation or demethylation |
| regulation of muscle cell apoptotic process |
| cellular response to amino acid stimulus |
| negative regulation of gene expression, epigenetic |
| positive regulation of smooth muscle cell proliferation |
| DNA modification |
| positive regulation of histone modification |
| positive regulation of chromatin organization |
| response to amino acid |
| negative regulation of vasculature development |
| regulation of gene silencing |
| regulation of smooth muscle cell proliferation |
| negative regulation of chromosome organization |
| regulation of histone modification |
| gene silencing |
| regulation of muscle cell differentiation |
| positive regulation of chromosome organization |
| regulation of chromatin organization |
| cellular response to acid chemical |
| regulation of gene expression, epigenetic |
| Ras protein signal transduction |
| macromolecule methylation |
| methylation |
| small GTPase mediated signal transduction |
| regulation of vasculature development |
| response to acid chemical |
| regulation of chromosome organization |
| negative regulation of organelle organization |
| negative regulation of protein modification process |
| cellular response to organonitrogen compound |
| positive regulation of organelle organization |
| cellular response to nitrogen compound |
| chromatin organization |
| negative regulation of cellular component organization |
| negative regulation of cell differentiation |
| DNA metabolic process |
| zinc ion binding |
| negative regulation of transcription by RNA polymerase II |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| positive regulation of cell population proliferation |
| negative regulation of developmental process |
| embryo development |
| negative regulation of cell death |
| response to organonitrogen compound |
| negative regulation of cellular protein metabolic process |
| cellular response to oxygen-containing compound |
| chromosome organization |
| response to nitrogen compound |
| negative regulation of protein metabolic process |
| negative regulation of transcription, DNA-templated |
| negative regulation of multicellular organismal process |
| positive regulation of cellular component organization |
| cellular response to endogenous stimulus |
| positive regulation of protein modification process |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| regulation of organelle organization |
| negative regulation of RNA metabolic process |
| negative regulation of cellular macromolecule biosynthetic process |
| RNA binding |
| negative regulation of nucleobase-containing compound metabolic process |
| DNA binding |
| negative regulation of macromolecule biosynthetic process |
| response to endogenous stimulus |
| negative regulation of cellular biosynthetic process |
| regulation of apoptotic process |
| negative regulation of biosynthetic process |
| response to oxygen-containing compound |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of programmed cell death |
| positive regulation of cellular protein metabolic process |
| regulation of cell population proliferation |
| regulation of cell death |
| intracellular signal transduction |
| positive regulation of protein metabolic process |
| negative regulation of gene expression |
| regulation of cell differentiation |
| regulation of protein modification process |
| positive regulation of gene expression |